NewsMarkets

Health

Novartis Drug Fails Key Study for Rare Neuromuscular Condition

The company's second major trial collapse in days follows the failure of its heart disease drug Pelacarsen.

2 publishers · 3 articles · first seen 8 Sept 2026 · updated 18h ago

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists The New York Times ·
  2. STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more STAT
  3. STAT+: Neuromuscular drug from Novartis fails in key study, adding to pressure on company STAT

In this story

  • Novartis